NCT06919913View on ClinicalTrials.gov

The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee

NANot yet recruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Prosthetic-joint Infection

Interventions

DIETARY_SUPPLEMENT

Culturelle Digestive Daily Probiotic Capsule

Each capsule contains 10 billion colony-forming units (CFU) of Lactobacillus rhamnosus GG. Subjects will self-administer 1 oral capsule daily for 6 weeks post operatively.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT06919913 - The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee | Biotech Hunter | Biotech Hunter